Gut Microbiome Composition Could Be Linked With Risk of Cognitive Impairment
In the study, the composition of the gut microbiome could also be affected by food insecurity, a known social determinant of health.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Importance of Skin-Gut Axis Communication in Homeostasis
The review explored the “emerging” term gut-skin axis and aimed to decipher the bidirectional signaling of the skin and gastrointestinal tract during homeostatic and disease states.
Scripted for Her: Addressing Preconception Health Through MTM
In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.
Atogepant Shows Superiority Over Topiramate for Migraine Prevention
Topline results from a phase 3 trial showed 64.1% of patients on atogepant achieved a 50% or greater reduction in mean monthly migraine days during months 4 to 6.
Semaglutide Lowers Risk of Kidney Disease Events in Patients With Type 2 Diabetes, CKD
Real-world effectiveness data showed semaglutide reduced the risk of major kidney disease events by 26%.
